Cited by 684Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.

Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

Open access

Martin, Lee J., Pan, Yan, Price, Ann C., Sterling, Wanda, Copeland, Neal G., Jenkins, Nancy A., Price, Donald L., Lee, Michael K.·2006·The Journal of Neuroscience

DOI 10.1523/jneurosci.4308-05.2006PMC PMC6381830

Open this paper in CoChat — free account Open PDF

Abstract

α-Synuclein (α-Syn) is enriched in nerve terminals. Two mutations in the α-Syn gene (Ala53→ Thr and Ala30→ Pro) occur in autosomal dominant familial Parkinson's disease. Mice overexpressing the human A53T mutant α-Syn develop a severe movement disorder, paralysis, and synucleinopathy, but the mechanisms are not understood. We examined whether transgenic mice expressing human wild-type or familial Parkinson's disease-linked A53T or A30P mutant α-syn develop neuronal degeneration and cell death. Mutant mice were examined at early- to mid-stage disease and at near end-stage disease. Age-matched nontransgenic littermates were controls. In A53T mice, neurons in brainstem and spinal cord exhibited large axonal swellings, somal chromatolytic changes, and nuclear condensation. Spheroid eosinophilic Lewy body-like inclusions were present in the cytoplasm of cortical neurons and spinal motor neurons. These inclusions contained human α-syn and nitrated synuclein. Motor neurons were depleted (∼75%) in A53T mice but were affected less in A30P mice. Axonal degeneration was present in many regions. Electron microscopy confirmed the cell and axonal degeneration and revealed cytoplasmic inclusions in dendrites and axons. Some inclusions were degenerating mitochondria and were positive for humanα-syn. Mitochondrial complex IV and V proteins were at control levels, but complex IV activity was reduced significantly in spinal cord. Subsets of neurons in neocortex, brainstem, and spinal cord ventral horn were positive for terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling, cleaved caspase-3, and p53. Mitochondria in neurons had terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling-positive matrices and p53 at the outer membrane. Thus, A53T mutant mice develop intraneuronal inclusions, mitochondrial DNA damage and degeneration, and apoptotic-like death of neocortical, brainstem, and motor neurons.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4308-05.2006

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108 · cited 1×
“p53 can mediate mitochondrial membrane permeabilization and apoptosis by activating Bax and Bak (Chipuk et al., 2004; Leu et al., 2004).”
Background
Dopaminergic Loss and Inclusion Body Formation in α-Synuclein Mice: Implications for Neurodegenerative Disorders
Masliah, E., Rockenstein, E. M., Veinbergs, I., Mallory, M. E., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,779
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S. H., Zaika, A. I., Petrenko, O., Chittenden, T. D., Pančoška, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,771
Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646
Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions
Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,567
Alpha-synuclein and neurodegenerative diseases
Goedert, M. (2001) · Nature reviews. Neuroscience · doi:10.1038/35081564 · Cited by 1,428

Flagged first, then by citations

Show all 59 references

2 of the 59 references couldn’t be matched to a known paper.

Research works printed but not linked: 6

Chayen J, Bitensky L, Butcher R (1973) Practical histochemistry. New York: Wiley.
2001, Int J Mol Med, 7, 455
2002, J Neurobiol, 5, 181
2002, Neurochem Res, 27, 1089
1997, J Comp Neurol, 378, 70
2000, J Biol Chem, 265, 18344

Sorted by citations

Items 301–400 of 684

Changes in Drp1 Function and Mitochondrial Morphology Are Associated with the α-Synuclein Pathology in a Transgenic Mouse Model of Parkinson’s Disease
Portz, P., & Lee, M. K. (2021) · Cells · doi:10.3390/cells10040885 · Cited by 55
Self-citation
NLRP3 inflammasomes: A potential target to improve mitochondrial biogenesis in Parkinson's disease
Khot, M., Sood, A., Tryphena, K. P., Khan, S. S., Srivastava, S., Singh, S. B., & Khatri, D. K. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175300 · Cited by 56
Brain regions susceptible to alpha-synuclein spreading
Guo, Y., Xiong, H., Chen, K., Zou, J.-J., & Lei, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01296-7 · Cited by 51
Involvement of Mitochondria in Parkinson’s Disease
Choong, C., & Mochizuki, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317027 · Cited by 58
Tickled PINK1: Mitochondrial homeostasis and autophagy in recessive Parkinsonism
Chu, C. T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.012 · Cited by 54
MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease
Arshad, A. R., Sulaiman, S. A., Saperi, A. A., Jamal, R., Ibrahim, N. M., & Murad, N. A. A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00352 · Cited by 54
Behavioral analysis of motor and non-motor symptoms in rodent models of Parkinson’s disease
Dunnett, S. B., & Lelos, M. J. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84003-8 · Cited by 52
Launching invasive, first‐in‐human trials against Parkinson's disease: Ethical considerations
Kimmelman, J., London, A. J., Ravina, B. M., Ramsay, T., Bernstein, M., Fine, A., Stahnisch, F. W., & Emborg, M. E. (2009) · Movement Disorders · doi:10.1002/mds.22712 · Cited by 52
mPOS is a novel mitochondrial trigger of cell death – implications for neurodegeneration
Coyne, L. P., & Chen, X. J. (2017) · FEBS Letters · doi:10.1002/1873-3468.12894 · Cited by 51
Neurons and Glia Interplay in α-Synucleinopathies
Mavroeidi, P., & Xilouri, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094994 · Cited by 55
Parkinson’s Disease: Exploring Different Animal Model Systems
Khan, E., Hasan, I., & Haque, M. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24109088 · Cited by 57
Novel subcellular localization for Î±-synuclein: possible functional consequences
Guardia-Laguarta, C., Area-Gomez, E., Schon, E. A., & Przedborski, S. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00017 · Cited by 44
Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
Xu, S., & Chan, P. (2015) · Biomolecules · doi:10.3390/biom5021122 · Cited by 56
Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures
Dhanwani, R., Lima-Júnior, J. R., Sethi, A., Pham, J. W., Williams, G. P., Frazier, A., Xu, Y., Amara, A. W., Standaert, D. G., Goldman, J. G., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00282-2 · Cited by 53
Neurodegenerative signaling factors and mechanisms in Parkinson's pathology
Goswami, P., Joshi, N., & Singh, S. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.06.008 · Cited by 51
Value of genetic models in understanding the cause and mechanisms of Parkinson’s disease
Moore, D. J., & Dawson, T. M. (2008) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-008-0045-7 · Cited by 50
Protein stability and aggregation in Parkinson's disease
Robinson, P. A. (2008) · Biochemical Journal · doi:10.1042/bj20080295 · Cited by 50
Differential regulation of small heat shock proteins in transgenic mouse models of neurodegenerative diseases
Wang, J., Martin, E. I., Gonzales, V., Borchelt, D., & Lee, M. K. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.11.009 · Cited by 50
Self-citation
A Noradrenergic Lesion Exacerbates Neurodegeneration in a Down Syndrome Mouse Model
Lockrow, J. P., Boger, H. A., Gerhardt, G. A., Aston‐Jones, G., Bachman, D., & Granholm, A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101218 · Cited by 49
The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease
Yasuda, T., & Mochizuki, H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0486-8 · Cited by 51
Chaperone-mediated autophagy controls the turnover of E3 ubiquitin ligase MARCHF5 and regulates mitochondrial dynamics
Nie, T., Tao, K., Zhu, L., Huang, L. H., Hu, S., Yang, R., Xu, P., Mao, Z., & Yang, Q. (2020) · Autophagy · doi:10.1080/15548627.2020.1848128 · Cited by 51
Alpha Synuclein in Parkinson’s Disease
Kragh, C. L., Romero‐Ramos, M., Halliday, G. M., & Jensen, P. H. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_14 · Cited by 48
Caenorhabditis elegans as a model system to study intercompartmental proteostasis: Interrelation of mitochondrial function, longevity, and neurodegenerative diseases
Kirstein, J., & Morimoto, R. I. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22292 · Cited by 52
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation
Lázaro, D. F., Dias, M. C., Čarija, A., Navarro, S., Madaleno, C. S., Tenreiro, S., Ventura, S., & Outeiro, T. F. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0402-8 · Cited by 49
The unlikely partnership between LRRK 2 and α‐synuclein in Parkinson's disease
Cresto, N., Gardier, C., Gubinelli, F., Gaillard, M., Liot, G., West Andrew, B., & Brouillet, E. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14182 · Cited by 49
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy
Braun, F., Abed, A., Sellung, D., Rogg, M., Woidy, M., Eikrem, Ø., Wanner, N., Gambardella, J., Laufer, S. D., Haas, F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci157782 · Cited by 50
Role of Alpha-Synuclein Protein Levels in Mitochondrial Morphology and Cell Survival in Cell Lines
Zhu, M., Li, W., & Lü, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036377 · Cited by 47
Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness
Cieri, D., Brini, M., & Calí, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.153 · Cited by 50
Update on the association between alpha‐synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease
Feng, S., Wang, Z., Yuan, Y., Sun, H., Chen, N., & Zhang, Y. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14699 · Cited by 47
Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation
Chavarría, C., Ivagnes, R., & Souza, J. M. (2022) · Biomolecules · doi:10.3390/biom12050655 · Cited by 47
New Insights into Mitochondria in Health and Diseases
Li, Y., Zhang, H., Yu, C., Dong, X., Yang, F., Wang, M., Wen, Z., Su, M., Li, B., & Yang, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189975 · Cited by 48
Neuroprotective effect of α-mangostin on mitochondrial dysfunction and α-synuclein aggregation in rotenone-induced model of Parkinson’s disease in differentiated SH-SY5Y cells
Hao, X.-M., Lian-da, L., Duan, C.-L., & Li, Y. (2017) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2017.1339349 · Cited by 46
splitGFP Technology Reveals Dose-Dependent ER-Mitochondria Interface Modulation by α-Synuclein A53T and A30P Mutants
Calí, T., Ottolini, D., Vicario, M., Catoni, C., Vallese, F., Cieri, D., Barazzuol, L., & Brini, M. (2019) · Cells · doi:10.3390/cells8091072 · Cited by 46
Cocaine Potentiates Astrocyte Toxicity Mediated by Human Immunodeficiency Virus (HIV-1) Protein gp120
Yang, Y., Yao, H., Lu, Y., Wang, C., & Buch, S. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013427 · Cited by 46
α‑synuclein induces apoptosis of astrocytes by causing dysfunction of the endoplasmic reticulum‑Golgi compartment
Liu, M., Qin, L., Wang, L., Tan, J., Zhang, H., Tang, J., Shen, X., Tan, L., & Wang, C. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9002 · Cited by 47
Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?
Hu, D., Liu, Z., & Qi, X. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.746873 · Cited by 44
Assembly of Lysine 63-linked Ubiquitin Conjugates by Phosphorylated α-Synuclein Implies Lewy Body Biogenesis
Liu, C., Fei, E., Jia, N., Wang, H., Tao, R.-S., Iwata, A., Nukina, N., Zhou, J., & Wang, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700422200 · Cited by 45
α-Synuclein, Lrrk2 and Their Interplay In Parkinson‘s Disease
Liu, G., Aliaga, L., & Cai, H. (2012) · Future Neurology · doi:10.2217/fnl.12.2 · Cited by 45
Impairment of Mitochondria in Adult Mouse Brain Overexpressing Predominantly Full-Length, N-Terminally Acetylated Human α-Synuclein
Sarafian, T. A., Ryan, C. M., Souda, P., Masliah, E., Kar, U. K., Vinters, H. V., Mathern, G. W., Faull, K. F., Whitelegge, J. P., & Watson, J. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063557 · Cited by 44
Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?
Wang, H., Dharmalingam, P., Vasquez, V., Mitra, J., Boldogh, I. R., Rao, K. S. J., Kent, T. A., MITRA, S. P., & Hegde, M. L. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.09.005 · Cited by 46
Genetic Mouse Models of Neurodegenerative Diseases
Trancikova, A. K., Ramonet, D., & Moore, D. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00012-1 · Cited by 47
Neural stem cells in the adult human brain.
González-Pérez, Ó. (2012) · PubMed · Cited by 44
Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice
Casadei, N., Pöhler, A.-M., Tomás‐Zapico, C., Torres-Peraza, J. F., Schwedhelm, I., Witz, A., Zamolo, I., de Heer, R. C., Spruijt, B. M., Noldus, L. P. J. J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt467 · Cited by 48
Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent
Hou, X., Chen, T. H., Koga, S., Bredenberg, J. M., Faroqi, A. H., Delenclos, M., Bu, G., Wszołek, Z. K., Carr, J. A., Ross, O. A., et al. (2023) · Brain Pathology · doi:10.1111/bpa.13175 · Cited by 42
Mitochondrial activity in the frontal cortex area 8 and angular gyrus in P arkinson's disease and P arkinson's disease with dementia
Garcia‐Esparcia, P., Koneti, A., Rodríguez-Oroz, M. C., Gago, B., del Rı́o, J. A., & Ferrer, I. (2016) · Brain Pathology · doi:10.1111/bpa.12474 · Cited by 41
Nrf2 activation attenuates the early suppression of mitochondrial respiration due to the α-synuclein overexpression
Fu, M., Wu, C., Lee, Y., Hung, C., Chen, I., & Wu, K. L. H. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.02.005 · Cited by 43
Iron in Neurodegenerative Disorders of Protein Misfolding: A Case of Prion Disorders and Parkinson's Disease
Singh, N., Haldar, S., Tripathi, A. K., McElwee, M. K., Horback, K., & Beserra, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5874 · Cited by 41
Genome instability and loss of protein homeostasis: converging paths to neurodegeneration?
Ainslie, A. P., Huiting, W., Barazzuol, L., & Bergink, S. (2021) · Open Biology · doi:10.1098/rsob.200296 · Cited by 42
Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy
Fournier, M., Vitte, J., Garrigue, J., Langui, D., Dullin, J.-P., Saurini, F., Hanoun, N., Pérez-Díaz, F., Cornilleau, F., Joubert, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006629 · Cited by 42
DNA Damage and Impairment of DNA Repair in Alzheimer's Disease
Obulesu, M., & Rao, D. M. (2010) · International Journal of Neuroscience · doi:10.3109/00207450903411133 · Cited by 43
Mitochondrial dysfunction in Parkinson’s disease
Hattori, N., & Sato, S. (2024) · Journal of Neural Transmission · doi:10.1007/s00702-024-02863-2 · Cited by 41
Protein Partners of α‐Synuclein in Health and Disease
Lassen, L. B., Reimer, L., Ferreira, N., Betzer, C., & Jensen, P. H. (2016) · Brain Pathology · doi:10.1111/bpa.12374 · Cited by 39
Comprehensive Perspectives on Experimental Models for Parkinson’s Disease
Ke, M., Chong, C., Zhu, Q., Zhang, K., Cai, C.-Z., Lu, J., Qin, D., & Su, H. (2021) · Aging and Disease · doi:10.14336/ad.2020.0331 · Cited by 41
3-Nitropropionic acid toxicity in hippocampus: Protection throughN-methyl-D-aspartate receptor antagonism
Karanian, D. A., Baude, A. S., Brown, Q. B., Parsons, C. G., & Bahr, B. A. (2006) · Hippocampus · doi:10.1002/hipo.20214 · Cited by 39
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
Valadas, J. S., Vos, M. H., & Verstreken, P. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12577 · Cited by 44
Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease
Petit, G. H., Berkovich, E., Hickery, M. S., Kallunki, P., Fog, K., Fitzer‐Attas, C. J., & Brundin, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060691 · Cited by 38
Pathogenic Mutation in VPS35 Impairs Its Protection against MPP+ Cytotoxicity
Bi, F., Li, F., Huang, C., & Zhou, H. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.5617 · Cited by 38
Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum
Melo, T. Q., Copray, S. C. V. M., & Ferrari, M. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2673-x · Cited by 38
RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy
Han, J., Jang, H.-S., Green, A. J. E., & Choi, Y. P. (2020) · Prion · doi:10.1080/19336896.2020.1724608 · Cited by 38
α-Synuclein aggregation and transmission in Parkinson’s disease: a link to mitochondria and lysosome
Wang, R., Sun, H., Ren, H., & Wang, G. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1756-9 · Cited by 38
Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson
Tassone, A., Meringolo, M., Ponterio, G., Bonsi, P., Schirinzi, T., & Martella, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087221 · Cited by 42
Late onset distal axonal swelling in YFP-H transgenic mice
Bridge, K., Berg, N., Adalbert, R., Babetto, E., Dias, T. B., Spillantini, M. G., Ribchester, R. R., & Coleman, M. P. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.002 · Cited by 38
Morphological analysis of mitochondria for evaluating the toxicity of α-synuclein in transgenic mice and isolated preparations by atomic force microscopy
Gao, G., Wang, Z., Lu, L., Duan, C., Wang, X., & Yang, H. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.057 · Cited by 36
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36
Detrimental deletions: mitochondria, aging and Parkinson's disease
Biskup, S., & Moore, D. J. (2006) · BioEssays · doi:10.1002/bies.20471 · Cited by 35
Protein clearing pathways in ALS.
Ferrucci, M., Fulceri, F., Toti, L., Soldani, P., Siciliano, G., Paparelli, A., & Fornai, F. (2011) · PubMed · doi:10.4449/aib.v149i1.1258 · Cited by 35
α‐Synuclein aggregation causes muscle atrophy through neuromuscular junction degeneration
Yang, Q., Wang, Y., Zhao, C., Pang, S., Lu, J., & Chan, P. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13123 · Cited by 35
D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model
Kim, D., Hwang, H., Choi, S., Kwon, S. H., Lee, S.-H., Park, J. H., Kim, S., & Ko, H. S. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0538-9 · Cited by 35
Interplay between Mitochondrial Protein Import and Respiratory Complexes Assembly in Neuronal Health and Degeneration
Needs, H. I., Protasoni, M., Henley, J. M., Prudent, J., Collinson, I. R., & Pereira, G. C. (2021) · Life · doi:10.3390/life11050432 · Cited by 32
Comparison between α-synuclein wild-type and A53T mutation in a progressive Parkinson's disease model
Lu, J., Sun, F., Ma, H., Qing, H., & Deng, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.07.007 · Cited by 35
The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson’s disease
Jęśko, H. M., Lenkiewicz, A. M., Wilkaniec, A., & Adamczyk, A. (2019) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2019-026 · Cited by 34
Axonal spheroids in neurodegeneration
Yu, Y., Hunter-Chang, S., Stepanova, E., & Deppmann, C. D. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103679 · Cited by 35
Gene therapy targeting mitochondrial pathway in Parkinson’s disease
Choong, C., & Mochizuki, H. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1616-4 · Cited by 34
Mitophagy regulation in aging and neurodegenerative disease
Banarase, T. A., Sammeta, S. S., Wankhede, N. L., Mangrulkar, S. V., Rahangdale, S. R., Aglawe, M. M., Taksande, B. G., Upaganlawar, A. B., Umekar, M. J., & Kale, M. B. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01057-6 · Cited by 35
A split-GFP tool reveals differences in the sub-mitochondrial distribution of wt and mutant alpha-synuclein
Vicario, M., Cieri, D., Vallese, F., Catoni, C., Barazzuol, L., Berto, P., Grinzato, A., Barbieri, L., Brini, M., & Calí, T. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2092-1 · Cited by 33
Mesenchymal Stem Cells Stabilize Axonal Transports for Autophagic Clearance of α-Synuclein in Parkinsonian Models
Oh, S. H., Lee, S. C., Kim, D. Y., Kim, H., Shin, J. Y., Ye, B. S., & Lee, P. H. (2017) · Stem Cells · doi:10.1002/stem.2650 · Cited by 32
Mitophagy impairment in neurodegenerative diseases: Pathogenesis and therapeutic interventions
Mani, S., Swargiary, G., & Chadha, R. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.01.001 · Cited by 33
Mitochondrial Pathobiology in Parkinson's Disease and Amyotrophic Lateral Sclerosis
Martin, L. J. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100348 · Cited by 32
Self-citation
Delivery to mitochondria: a narrower approach for broader therapeutics
Malhi, S. S., & Murthy, R. S. R. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.694864 · Cited by 31
Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice
Vivacqua, G., Biagioni, F., Yu, S., Casini, A., Bucci, D., D’Este, L., & Fornai, F. (2012) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2012.04.003 · Cited by 32
l-Tyrosine Induces DNA Damage in Brain and Blood of Rats
Prá, S. D.-T. D., Ferreira, G. K., Carvalho‐Silva, M., Vieira, J. S., Scaini, G., Leffa, D. D., Fagundes, G. E., Bristot, B. N., Borges, G. D., Ferreira, G. C., et al. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1207-9 · Cited by 32
Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson’s disease
Lee, Y., Heo, G., Lee, K. M., Kim, A. H., Chung, K. W., Im, E., Chung, H. Y., & Lee, J. (2017) · Brain Research · doi:10.1016/j.brainres.2017.03.018 · Cited by 32
Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson’s Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity
Stanojlović, M., Pallais, J. P., Vijayakumar, A., & Kotz, C. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01682-x · Cited by 33
Protective role of olesoxime against wild‐type α‐synuclein‐induced toxicity in human neuronally differentiated SHSY ‐5 Y cells
Gouarné, C., Tracz, J., Giraudon‐Paoli, M., Deluca, V., Seimandi, M., Tardif, G., Xilouri, M., Stefanis, L., Bordet, T., & Pruss, R. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12939 · Cited by 31
Transgenic overexpression of the alpha-synuclein interacting protein synphilin-1 leads to behavioral and neuropathological alterations in mice
Nuber, S., Franck, T., Wolburg, H., Schumann, U., Casadei, N., Fischer, K., Calaminus, C., Pichler, B. J., Chanarat, S., Teismann, P., et al. (2009) · Neurogenetics · doi:10.1007/s10048-009-0212-2 · Cited by 34
Alpha synuclein modulates mitochondrial Ca2+ uptake from ER during cell stimulation and under stress conditions
Ramezani, M., Wagenknecht-Wiesner, A., Wang, T., Holowka, D. A., Eliezer, D., & Baird, B. A. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00578-x · Cited by 33
Oxidative Stress, Neuroinflammation, and Neurodegeneration
Gao, H., Zhou, H., & Hong, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_5 · Cited by 30
Mitochondrial dysfunction in Parkinson’s disease
Бунеева, О. А., & Medvedev, A. E. (2011) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750811040032 · Cited by 30
Dynamic modelling of protein and oxidative metabolisms simulates the pathogenesis of Parkinson's disease
Cloutier, M., & Wellstead, P. E. (2012) · IET Systems Biology · doi:10.1049/iet-syb.2011.0075 · Cited by 30
Atorvastatin attenuates mitochondrial toxin‐induced striatal degeneration, with decreasing iNOS/c‐Jun levels and activating ERK/Akt pathways
Lee, S., Chu, K., Park, J., Hong, N. H., Im, W., Kang, L., Han, Z., Jung, K., Kim, M., & Kim, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05044.x · Cited by 31
Mitochondrial Morphogenesis, Distribution, and Parkinson Disease
Yang, Y., & Lu, B. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b2048c · Cited by 31
Mitochondrial dynamic changes in health and genetic diseases
Chen, L., Winger, A. J., & Knowlton, A. A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3663-y · Cited by 31
Modulation of α-synuclein expression in transgenic animals for modelling synucleinopathies — is the juice worth the squeeze?
Buchman, V. L., & Ninkina, N. N. (2008) · Neurotoxicity Research · doi:10.1007/bf03033857 · Cited by 29
Metabolic Features of Brain Function with Relevance to Clinical Features of Alzheimer and Parkinson Diseases
Butterfield, D. A., Favia, M., Spera, I., Campanella, A., Lanza, M., & Castegna, A. (2022) · Molecules · doi:10.3390/molecules27030951 · Cited by 29
Over‐expression of alpha‐synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a transgenic mouse strain
Siebert, H., Kahle, P. J., Kramer, M. L., Isik, T., Schlüter, O. M., Schulz‐Schaeffer, W., & Brück, W. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06832.x · Cited by 28
Rabs, SNAREs and α-synuclein — Membrane trafficking defects in synucleinopathies
Chua, C. E. L., & Tang, B. L. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.03.002 · Cited by 28
Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson’s Disease
Stanojlović, M., Pallais, J. P., & Kotz, C. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00702 · Cited by 27
Neuroprotection against neurodegenerative diseases
Chiba, T., Nishimoto, I., Aiso, S., & Matsuoka, M. (2007) · Molecular Neurobiology · doi:10.1007/bf02700624 · Cited by 27
Pale Body-Like Inclusion Formation and Neurodegeneration following Depletion of 26S Proteasomes in Mouse Brain Neurones are Independent of α-Synuclein
Paine, S., Anderson, G. W., Bedford, K., Lawler, K., Mayer, R. J., Lowe, J. S., & Bedford, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054711 · Cited by 27
Spinal cord degeneration in C57BL/6N mice following induction of experimental parkinsonism with MPTP
Samantaray, S., Knaryan, V. H., Butler, J. T., Ray, S. K., & Banik, N. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05091.x · Cited by 27

Authors: Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K.
Affiliations: Johns Hopkins University (US)
National Institutes of Health (US)
ORCID: Martin, Lee J.
Jenkins, Nancy A.
Lee, Michael K.
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2006-01-04
Volume: 26
Issue: 1
Pages: 41-50
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.4308-05.2006
PMC: PMC6381830
OpenAlex: W2084910880
Cited by: 684
References: 59
Citations by year: 2026: 15 · 2025: 14 · 2024: 24 · 2023: 27 · 2022: 37 · 2021: 34 · 2020: 27 · 2019: 34 · 2018: 39 · 2017: 43 · 2016: 34 · 2015: 30 · 2014: 35 · 2013: 41 · 2012: 49
FWCI: 26.91
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 181 d)
Locations: Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (NS38377)
U.S. Public Health Service
National Institute on Aging (AG 16282, R01AG016282)
National Institute of Neurological Disorders and Stroke (NS 38377, R01NS052098, NS34 100, P01NS038065, R56NS038065, P50NS038377, NS 38065, R01NS034100, R01NS038065, NS52098)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: alpha-synuclein, Parkinson's disease, A53T mutation, A30P mutation, transgenic mice, mitochondrial degeneration, neuronal cell death, motor neuron degeneration, axonal degeneration, Lewy bodies, mitochondrial DNA damage, apoptosis, caspase-3, p53, mitochondrial complex IV, synucleinopathies
MeSH terms: Alanine, Animals, Brain Stem, DNA Damage, Humans, Mice, Transgenic, Mitochondria, Mutation, Nerve Degeneration, Parkinson Disease, Threonine, Cell Death, Neocortex, Mice, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks